Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-012593
Filing Date
2023-05-04
Accepted
2023-05-04 16:52:58
Documents
67
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q siga20230331_10q.htm   iXBRL 10-Q 631244
2 EXHIBIT 31.1 ex_463926.htm EX-31.1 15595
3 EXHIBIT 31.2 ex_463927.htm EX-31.2 15706
4 EXHIBIT 32.1 ex_463928.htm EX-32.1 6025
5 EXHIBIT 32.2 ex_463929.htm EX-32.2 5906
  Complete submission text file 0001437749-23-012593.txt   4317023

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA siga-20230331.xsd EX-101.SCH 54624
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE siga-20230331_cal.xml EX-101.CAL 36011
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE siga-20230331_def.xml EX-101.DEF 323164
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE siga-20230331_lab.xml EX-101.LAB 275972
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE siga-20230331_pre.xml EX-101.PRE 346134
61 EXTRACTED XBRL INSTANCE DOCUMENT siga20230331_10q_htm.xml XML 570057
Mailing Address 31 EAST 62ND STREET NEW YORK NY 10065
Business Address 31 EAST 62ND STREET NEW YORK NY 10065 212-672-9100
SIGA TECHNOLOGIES INC (Filer) CIK: 0001010086 (see all company filings)

EIN.: 133864870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38436 | Film No.: 23889698
SIC: 2834 Pharmaceutical Preparations